Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Invested Capital (2020 - 2025)

Historic Invested Capital for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $32.1 million.

  • Bolt Biotherapeutics' Invested Capital fell 5543.45% to $32.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.1 million, marking a year-over-year decrease of 5543.45%. This contributed to the annual value of $57.2 million for FY2024, which is 4926.6% down from last year.
  • Latest data reveals that Bolt Biotherapeutics reported Invested Capital of $32.1 million as of Q3 2025, which was down 5543.45% from $38.8 million recorded in Q2 2025.
  • Bolt Biotherapeutics' Invested Capital's 5-year high stood at $303.2 million during Q1 2021, with a 5-year trough of $32.1 million in Q3 2025.
  • Its 5-year average for Invested Capital is $152.5 million, with a median of $142.1 million in 2023.
  • In the last 5 years, Bolt Biotherapeutics' Invested Capital surged by 65924.02% in 2021 and then plummeted by 5543.45% in 2025.
  • Over the past 5 years, Bolt Biotherapeutics' Invested Capital (Quarter) stood at $250.1 million in 2021, then plummeted by 31.43% to $171.5 million in 2022, then plummeted by 34.26% to $112.7 million in 2023, then tumbled by 49.27% to $57.2 million in 2024, then crashed by 43.88% to $32.1 million in 2025.
  • Its last three reported values are $32.1 million in Q3 2025, $38.8 million for Q2 2025, and $46.8 million during Q1 2025.